Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3.08%1.24B | 0.59%1.19B | 4.06%1.15B | 1.36%4.7B | 6.41%1.21B | 0.25%1.2B | 1.03%1.18B | -2.20%1.11B | 3.85%4.64B | 0.26%1.14B |
| Operating revenue | 3.08%1.24B | 0.59%1.19B | 4.06%1.15B | 1.36%4.7B | 6.41%1.21B | 0.25%1.2B | 1.03%1.18B | -2.20%1.11B | 3.85%4.64B | 0.26%1.14B |
| Cost of revenue | 1.09%744M | -2.77%702M | 1.65%679M | 3.87%2.85B | 6.50%721M | 3.52%736M | 4.64%722M | 0.75%668M | -3.35%2.74B | -2.45%677M |
| Gross profit | 6.24%494M | 5.90%485M | 7.71%475M | -2.27%1.85B | 6.29%490M | -4.52%465M | -4.18%458M | -6.37%441M | 16.38%1.9B | 4.54%461M |
| Operating expense | 0.00%419M | 1.45%421M | 3.68%423M | 1.91%1.65B | -3.06%412M | 5.81%419M | 2.47%415M | 2.26%408M | 9.22%1.62B | 15.80%425M |
| Selling and administrative expenses | 0.75%269M | 0.00%275M | 4.87%280M | 0.37%1.09B | 1.47%277M | 0.38%267M | 1.85%275M | -2.20%267M | 9.07%1.08B | 6.64%273M |
| -General and administrative expense | 0.75%269M | 0.00%275M | 4.87%280M | 0.37%1.09B | 1.47%277M | 0.38%267M | 1.85%275M | -2.20%267M | 9.07%1.08B | 6.64%273M |
| Depreciation amortization depletion | 5.71%74M | 4.35%72M | 2.99%69M | 3.68%282M | 4.11%76M | 1.45%70M | 1.47%69M | 8.06%67M | 7.94%272M | 17.74%73M |
| -Depreciation and amortization | 5.71%74M | 4.35%72M | 2.99%69M | 3.68%282M | 4.11%76M | 1.45%70M | 1.47%69M | 8.06%67M | 7.94%272M | 17.74%73M |
| Other operating expenses | -7.32%76M | 4.23%74M | 0.00%74M | 6.32%286M | -25.32%59M | 34.43%82M | 5.97%71M | 15.63%74M | 11.16%269M | 61.22%79M |
| Operating profit | 63.04%75M | 48.84%64M | 57.58%52M | -27.01%200M | 116.67%78M | -49.45%46M | -41.10%43M | -54.17%33M | 90.28%274M | -51.35%36M |
| Net non-operating interest income (expenses) | 0.00%-35M | 8.33%-33M | 0.00%-36M | -11.81%-142M | -2.94%-35M | 2.78%-35M | -5.88%-36M | -56.52%-36M | -60.76%-127M | -47.83%-34M |
| Non-operating interest income | ---- | ---- | ---- | ---- | ---- | --1M | ---- | ---- | ---- | ---- |
| Non-operating interest expense | 2.94%35M | -11.43%31M | 0.00%35M | 11.29%138M | 3.03%34M | -2.86%34M | 2.94%35M | 59.09%35M | 61.04%124M | 43.48%33M |
| Total other finance cost | ---- | 100.00%2M | 0.00%1M | 33.33%4M | 0.00%1M | 0.00%1M | --1M | 0.00%1M | 50.00%3M | --1M |
| Other net income (expenses) | 150.00%3M | -525.00%-25M | 105.00%1M | 59.62%-86M | 5.08%-56M | 33.33%-6M | -33.33%-4M | 85.71%-20M | -110.89%-213M | 32.18%-59M |
| Gain on sale of security | 300.00%4M | ---4M | 100.00%4M | 266.67%5M | 200.00%2M | 150.00%1M | ---- | 300.00%2M | 80.00%-3M | -128.57%-2M |
| Special income (charges) | 50.00%-6M | -140.00%-24M | 76.00%-6M | 52.59%-110M | 8.70%-63M | -9.09%-12M | -25.00%-10M | 82.39%-25M | -120.95%-232M | 29.59%-69M |
| -Less:Restructuring and mergern&acquisition | 20.00%6M | -90.00%1M | -78.26%5M | 100.00%46M | -33.33%8M | 25.00%5M | 66.67%10M | 2,400.00%23M | 666.67%23M | 0.00%12M |
| -Less:Impairment of capital assets | ---- | ---- | ---- | -68.57%55M | ---- | ---- | ---- | ---- | 78.57%175M | ---- |
| -Less:Write off | --0 | --23M | -50.00%1M | -73.53%9M | --0 | 0.00%7M | --0 | -98.68%2M | 750.00%34M | -958.33%-127M |
| -Gain on sale of business | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Income before tax | 760.00%43M | 100.00%6M | 173.91%17M | 57.58%-28M | 77.19%-13M | -89.13%5M | -91.67%3M | 74.73%-23M | -83.33%-66M | -58.33%-57M |
| Income tax | 900.00%8M | 400.00%3M | 183.33%5M | -7.69%-14M | -50.00%-6M | -116.67%-1M | -111.11%-1M | 75.00%-6M | 40.91%-13M | 75.00%-4M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 483.33%35M | -25.00%3M | 170.59%12M | 73.58%-14M | 86.79%-7M | -85.00%6M | -85.19%4M | 74.63%-17M | -278.57%-53M | -165.00%-53M |
| Net income continuous operations | 483.33%35M | -25.00%3M | 170.59%12M | 73.58%-14M | 86.79%-7M | -85.00%6M | -85.19%4M | 74.63%-17M | -278.57%-53M | -165.00%-53M |
| Noncontrolling interests | 20.00%6M | 100.00%6M | 66.67%5M | -26.09%17M | 50.00%6M | -16.67%5M | -40.00%3M | -62.50%3M | 15.00%23M | -42.86%4M |
| Net income attributable to the company | 2,800.00%29M | -400.00%-3M | 135.00%7M | 59.21%-31M | 77.19%-13M | -97.06%1M | -95.45%1M | 73.33%-20M | -123.53%-76M | -111.11%-57M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 2,800.00%29M | -400.00%-3M | 135.00%7M | 59.21%-31M | 77.19%-13M | -97.06%1M | -95.45%1M | 73.33%-20M | -123.53%-76M | -111.11%-57M |
| Diluted earnings per share | 2,800.00%0.29 | -400.00%-0.03 | 135.00%0.07 | 59.21%-0.31 | 77.19%-0.13 | -97.06%0.01 | -95.45%0.01 | 73.33%-0.2 | -123.53%-0.76 | -111.11%-0.57 |
| Basic earnings per share | 2,800.00%0.29 | -400.00%-0.03 | 135.00%0.07 | 59.21%-0.31 | 77.19%-0.13 | -97.06%0.01 | -95.45%0.01 | 73.33%-0.2 | -123.53%-0.76 | -111.11%-0.57 |
| Dividend per share | 0.00%0.12 | 0.00%0.12 | 0.00%0.12 | 0.00%0.48 | 0.00%0.12 | 0.00%0.12 | 0.00%0.12 | 0.00%0.12 | 0.00%0.48 | 0.00%0.12 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.